GLP2-T
GLP2-T is an innovative peptide that functions as a dual GLP-1 and GIP receptor agonist, establishing it as a highly effective option for fat loss and metabolic health improvement. By activating both glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) receptors, GLP2-T suppresses appetite, enhances insulin sensitivity, optimizes glucose metabolism, and promotes fat burning. Its unique dual-action mechanism reduces hunger and food intake while increasing energy expenditure and fat oxidation, making it a potent tool for weight management. Clinical trials have demonstrated remarkable outcomes, with patients achieving 20-25% body weight reduction, alongside improvements in cardiovascular health and metabolic indicators such as blood pressure and cholesterol.
Select Size
Account required · Research professionals only
Live Certificates of Analysis
Lot: RH-2026-001Research Application
GLP2-T (Tirzepatide analog) is a dual GIP and GLP-1 receptor agonist studied in metabolic research for glycemic regulation and insulin sensitivity signaling pathways.
Research Use Only. This compound is supplied strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary administration. By purchasing you confirm compliance with all applicable regulations.
Compound Specifications
| Compound | GLP2-T |
| Sequence | Tyr-{Aib}-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{Aib}-Leu-Asp-Lys-Ile-Ala-Gln-Lys({AEEAc-AEEAc-γ-Glu-19-carboxynonadecanoyl})-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Molecular Formula | C225H348N48O68 |
| Molecular Weight | 4813.5 g/mol |
| Purity | ≥99% by HPLC |
| Identity | Confirmed by Mass Spectrometry |
| Appearance | White lyophilized powder |
Done shopping?
Review your research compounds or proceed to checkout.
Similar Research Peptides
The KLOW peptide blend is a proprietary, synergetic fusion of four distinct, highly researched peptides:…
Epithalon is reported to activate telomerase and support telomere maintenance, promoting cellular longevity and reduced…
GLP1-S, a GLP-1 receptor agonist, was initially developed for type 2 diabetes but is now…
AOD 9604 offers several key advantages, such as enhanced fat metabolism, which can be particularly…
Certificate of Analysis
Welcome Back
3for2